Correlation Between Talis Biomedical and Icad

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Talis Biomedical and Icad at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Talis Biomedical and Icad into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Talis Biomedical Corp and icad inc, you can compare the effects of market volatilities on Talis Biomedical and Icad and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Talis Biomedical with a short position of Icad. Check out your portfolio center. Please also check ongoing floating volatility patterns of Talis Biomedical and Icad.

Diversification Opportunities for Talis Biomedical and Icad

-0.41
  Correlation Coefficient

Very good diversification

The 3 months correlation between Talis and Icad is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Talis Biomedical Corp and icad inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on icad inc and Talis Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Talis Biomedical Corp are associated (or correlated) with Icad. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of icad inc has no effect on the direction of Talis Biomedical i.e., Talis Biomedical and Icad go up and down completely randomly.

Pair Corralation between Talis Biomedical and Icad

Given the investment horizon of 90 days Talis Biomedical Corp is expected to under-perform the Icad. In addition to that, Talis Biomedical is 1.15 times more volatile than icad inc. It trades about -0.06 of its total potential returns per unit of risk. icad inc is currently generating about 0.03 per unit of volatility. If you would invest  165.00  in icad inc on August 30, 2024 and sell it today you would earn a total of  12.00  from holding icad inc or generate 7.27% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy88.28%
ValuesDaily Returns

Talis Biomedical Corp  vs.  icad inc

 Performance 
       Timeline  
Talis Biomedical Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Talis Biomedical Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's forward indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
icad inc 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in icad inc are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Icad exhibited solid returns over the last few months and may actually be approaching a breakup point.

Talis Biomedical and Icad Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Talis Biomedical and Icad

The main advantage of trading using opposite Talis Biomedical and Icad positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Talis Biomedical position performs unexpectedly, Icad can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Icad will offset losses from the drop in Icad's long position.
The idea behind Talis Biomedical Corp and icad inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device